CVI Holdings’s Panbela Therapeutics, Inc. Common Stock PBLA Stock Holding History

CVI Holdings’s Portfolio PBLA Stock Details PBLA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-658	Closed	-$175K	–	429
2023 Q1	$175K	Buy	+658	New	+$638K	0.07%	139
2021 Q3	–	Sell	-2	Closed	-$118K	–	980
2021 Q2	$118K	Buy	+2	New	+$195K	0.01%	573
2020 Q4	–	Sell	-3	Closed	-$238K	–	205
2020 Q3	$238K	Buy	+3	New	+$210K	0.1%	59

Other funds holding PBLA

Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return

Walleye Capital New York $24B AUM 37.67% 1-Year Est. Return

Hudson Bay Capital Management Stamford, Connecticut $29B AUM 30.2% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

CVI Holdings's PBLA Position: Q2 2023 in Review

CVI Holdings sold out of Panbela Therapeutics, Inc. Common Stock (PBLA) in Q2 2023, closing a stake of 658 shares — an estimated $175K sold.

CVI Holdings first reported a position in PBLA in Q3 2020 and held it in 3 quarters. The position peaked at $238K in Q3 2020. 6 funds tracked by Wall St. Rank hold PBLA as of Q2 2023.

CVI Holdings reported no remaining Panbela Therapeutics, Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
CVI Holdings sold 658 Panbela Therapeutics, Inc. Common Stock shares in Q2 2023, an estimated $175K.
CVI Holdings first reported a position in Panbela Therapeutics, Inc. Common Stock in Q3 2020 and held it in 3 quarters.
CVI Holdings's Panbela Therapeutics, Inc. Common Stock position peaked at $238K in Q3 2020.
6 funds tracked by Wall St. Rank held Panbela Therapeutics, Inc. Common Stock as of Q2 2023.

Based on CVI Holdings's 13F filing for Q2 2023, filed 11 Aug 2023.